The complex world of kidney microRNAs

Kidney International

Volumn 80, Issue 4, 2011, Pages 334-337

  Kasinath, Balakuntalam S ^a   Feliers, Denis ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; MICRORNA; MICRORNA 191; MICRORNA 200B; MICRORNA 200C; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1; TYPE I COLLAGEN ALPHA2 CHAIN; TYPE IV COLLAGEN ALPHA1 CHAIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZEB1 PROTEIN; ZEB2 PROTEIN;

ALBUMINURIA; DIABETIC NEPHROPATHY; GENE EXPRESSION REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 80052190574     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.165     Document Type: Note

References (11)

1. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. N at Rev Genet 2010;11: 597-610.
2. Kasinath BS, Feliers D, Sataranatarajan K e t al. Regulation of mRNA translation in renal physiology and disease. Am J Physiol Renal Physiol 2009;297: F1153-F1165.
3. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. S cience 2007; 318: 1931-1934.
4. Kato M, Arce L, Wang M e t al. A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. K idney Int 2011;80: 358-368.
5. Park IS, Kiyomoto H, Abboud SL e t al. Expression of transforming growth factor beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 1997;46: 473-480. (Pubitemid 27090278)
6. Krupa A, Jenkins R, Luo DD e t al. Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 438-447.
7. Wang B, Herman-Edelstein H, Koh P e t al. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effect of transforming growth factor beta. D iabetes 2010;59: 1794-1802.
8. Chung ACK, Huang XR, Meng X e t al. miR-192 mediates TGF-β/Smad3- driven renal fibrosis. J Am Soc Nephrol 2010;21: 1317-1325.
9. Oba S, Kumano S, Suzuki E e t al. miR-200b precursor can ameliorate renal tubulo-interstitial fibrosis. P LoS One [online] 2010; 5: e 13614.
10. Wang Q, Wang Y, Minto AW e t al. M icroRNA-377 is upregulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008; 22: 4126-4135.
11. Long J, Wang Y, Wang W et al. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J Biol Chem 2011; 286: 11837-11848.